(2020) reported that Jiawei Xiaoyao significantly improved gastrointestinal symptoms in patients with functional dyspepsia, but the accompanying improvements in Hamilton Depression and Anxiety Scale scores did not reach statistical significance.
← all excerpts
Inflammation-neurotrophin synergy of Xiao-yao-san-type botanical drug formulations in depressive disorders: a qualitative synthesis of recent human studies with taxonomic and compositional characterisation.
1
—
—